PMC:7283670 / 83518-83736 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T277","span":{"begin":31,"end":36},"obj":"Body_part"}],"attributes":[{"id":"A277","pred":"fma_id","subj":"T277","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"change of the SOFA (sequential organ failure assessment) (baseline, during treatment (cycle 1 and 2 every 12 hr), number of participants with treatment‐related side effects as assessed by Common Terminology Criteria fo"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T176","span":{"begin":31,"end":36},"obj":"Body_part"}],"attributes":[{"id":"A176","pred":"uberon_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"change of the SOFA (sequential organ failure assessment) (baseline, during treatment (cycle 1 and 2 every 12 hr), number of participants with treatment‐related side effects as assessed by Common Terminology Criteria fo"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T690","span":{"begin":31,"end":36},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"change of the SOFA (sequential organ failure assessment) (baseline, during treatment (cycle 1 and 2 every 12 hr), number of participants with treatment‐related side effects as assessed by Common Terminology Criteria fo"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1948","span":{"begin":124,"end":136},"obj":"Species"}],"attributes":[{"id":"A1948","pred":"tao:has_database_id","subj":"1948","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"change of the SOFA (sequential organ failure assessment) (baseline, during treatment (cycle 1 and 2 every 12 hr), number of participants with treatment‐related side effects as assessed by Common Terminology Criteria fo"}